Gilead Sciences Agrees To $202M Settlement For Using Speaker Programs To Pay Kickbacks To Doctors To Induce Them To Prescribe Gilead’s Drugs
On April 29, 2025, the United States Attorney for the Southern District of New York announced that the United States has settled a civil fraud lawsuit against Gilead Sciences, Inc. (“Gilead”), a large pharmaceutical manufacturer, that, among other things, develops, manufactures, and sells d[...]